These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 28420387
21. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Burbelo PD, Meoli E, Leahy HP, Graham J, Yao K, Oh U, Janik JE, Mahieux R, Kashanchi F, Iadarola MJ, Jacobson S. Retrovirology; 2008 Oct 20; 5():96. PubMed ID: 18937847 [Abstract] [Full Text] [Related]
22. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients. Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ. J Med Virol; 2008 Mar 20; 80(3):392-8. PubMed ID: 18205234 [Abstract] [Full Text] [Related]
23. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Best I, Adaui V, Verdonck K, González E, Tipismana M, Clark D, Gotuzzo E, Vanham G. Clin Exp Immunol; 2006 Nov 20; 146(2):226-33. PubMed ID: 17034574 [Abstract] [Full Text] [Related]
24. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR. J Immunol; 2004 Feb 01; 172(3):1735-43. PubMed ID: 14734756 [Abstract] [Full Text] [Related]
25. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP. Niederer HA, Laydon DJ, Melamed A, Elemans M, Asquith B, Matsuoka M, Bangham CR. Virol J; 2014 Sep 30; 11():172. PubMed ID: 25270762 [Abstract] [Full Text] [Related]
26. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Evangelista A, Maroushek S, Minnigan H, Larson A, Retzel E, Haase A, Gonzalez-Dunia D, McFarlin D, Mingioli E, Jacobson S. Microb Pathog; 1990 Apr 30; 8(4):259-78. PubMed ID: 2200942 [Abstract] [Full Text] [Related]
27. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina. Benencio P, Fraile Gonzalez SA, Ducasa N, Page K, Berini CA, Biglione MM. Retrovirology; 2020 Sep 03; 17(1):29. PubMed ID: 32883310 [Abstract] [Full Text] [Related]
28. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load. de Souza JG, da Fonseca FG, Martins ML, Martins CP, de Carvalho LD, Coelho-dos-Reis JG, Carneiro-Proietti AB, Martins-Filho OA, Barbosa-Stancioli EF, GIPH. J Clin Virol; 2011 Jan 03; 50(1):13-8. PubMed ID: 20951636 [Abstract] [Full Text] [Related]
29. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Primo J, Siqueira I, Nascimento MC, Oliveira MF, Farre L, Carvalho EM, Bittencourt AL. Braz J Med Biol Res; 2009 Aug 03; 42(8):761-4. PubMed ID: 19578703 [Abstract] [Full Text] [Related]
30. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S. J Infect Dis; 2001 Jan 15; 183(2):197-205. PubMed ID: 11120926 [Abstract] [Full Text] [Related]
31. Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil. Domingos JA, Soares LS, Bandeira LM, Bonin CM, Vicente AC, Zanella L, Puga MA, Tozetti IA, Motta-Castro AR, da Cunha RV. PLoS One; 2017 Jan 15; 12(4):e0174869. PubMed ID: 28376092 [Abstract] [Full Text] [Related]
33. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network. Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA, Teixeira-Carvalho A, Peruhype-Magalhães V, Carneiro-Proietti AB. Inflamm Allergy Drug Targets; 2008 Jun 15; 7(2):98-107. PubMed ID: 18691139 [Abstract] [Full Text] [Related]
34. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers. Rego FF, de Oliveira T, Giovanetti M, Galvão-Castro B, Gonçalves Mde S, Alcantara LC. AIDS Res Hum Retroviruses; 2016 Mar 15; 32(3):279-83. PubMed ID: 26472535 [Abstract] [Full Text] [Related]
36. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis. Mozhgani SH, Piran M, Zarei-Ghobadi M, Jafari M, Jazayeri SM, Mokhtari-Azad T, Teymoori-Rad M, Valizadeh N, Farajifard H, Mirzaie M, Khamseh A, Rafatpanah H, Rezaee SA, Norouzi M. Retrovirology; 2019 Dec 30; 16(1):46. PubMed ID: 31888669 [Abstract] [Full Text] [Related]
37. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis. Mozhgani SH, Jahantigh HR, Rafatpanah H, Valizadeh N, Mohammadi A, Basharkhah S, Rezaee SA. Neurodegener Dis; 2018 Dec 30; 18(2-3):150-155. PubMed ID: 29990995 [Abstract] [Full Text] [Related]
38. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load. Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E, Takashima H, Kubota R. Int J Mol Sci; 2024 Jun 22; 25(13):. PubMed ID: 38999966 [Abstract] [Full Text] [Related]
40. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment. Césaire R, Dehée A, Lézin A, Désiré N, Bourdonné O, Dantin F, Béra O, Smadja D, Abel S, Cabié A, Sobesky G, Nicolas JC. AIDS Res Hum Retroviruses; 2001 Jun 10; 17(9):799-805. PubMed ID: 11429121 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]